Bryon D. Hayes

Grantek

Director - Life Sciences

Bryon Hayes, P.Eng. is the Director of Life Sciences at Grantek. He has 20 years of experience working within in the life sciences industry. At Grantek, he is responsible for translating current trends in the life sciences landscape into actionable technical partnership opportunities, training plans, and growth strategies. Bryon has been an active member of ISPE since 2009. Within ISPE, he is a member of both the Pharma 4.0 and the Blockchain special interest groups. As part of his active participation with the Pharma 4.0 SIG, he participates in both the Impact and Maturity Working Group and the Continued Process Verification Working Group. In 2019, he presented about Data Integrity at the ISPE Canada Affiliate Education and Product Symposium. Alongside his involvement in ISPE, he is also an active member of ISA, serving on both the ISA88 and ISA112 standards committees, and actively participating in the Food & Pharmaceutical Industries, Process Measurement & Control, and Smart Manufacturing & IIOT divisions.

Features

Using Technology for Continuous Process Verification 4.0

1 January 2023

In this article, potential Pharma 4.0™ technological solutions that can enhance continuous process verification (CPV) 4.0 are discussed. The necessary paradigm shift will allow companies to predict deviations more accurately, perform root cause...

Bryon D. Hayes

Related Articles